Malignant Neoplasm Clinical Trials in Wuhan, Hubei
4 recruitingWuhan, Hubei, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Malignant Neoplasm
Tyligand Pharmaceuticals (Suzhou) Limited440 enrolled19 locationsNCT06385925
Recruiting
Not Applicable
68Ga-FAPI PET/CT in Malignant Tumors
PET/CTMalignant NeoplasmFibroblast Activation Protein Inhibitor
Zhongnan Hospital500 enrolled1 locationNCT05034146
Recruiting
Early Phase 1
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Malignant Neoplasm of Liver
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology100 enrolled1 locationNCT06383520
Recruiting
Integrin αvβ6-targeted PET in Malignant Tumors
PET/CTMalignant Neoplasm
Zhongnan Hospital200 enrolled1 locationNCT05835570